Ontology highlight
ABSTRACT:
SUBMITTER: Miller CM
PROVIDER: S-EPMC5899299 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature
Miller Colton M CM Wan W Brad WB Seth Punit P PP Harris Edward N EN
Nucleic acid therapeutics 20180213 2
Second-generation (Gen 2) Antisense oligonucleotides (ASOs) show increased nuclease stability and affinity for their RNA targets, which has translated to improved potency and therapeutic index in the clinic. Gen 2 ASOs are typically modified using the phosphorothioate (PS) backbone modification, which enhances ASO interactions with plasma, cell surface, and intracellular proteins. This facilitates ASO distribution to peripheral tissues and also promotes cellular uptake after injection into anima ...[more]